These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20594429)

  • 21. GP utilisation by education level among adults with COPD or asthma: a cross-sectional register-based study.
    Hetlevik Ø; Melbye H; Gjesdal S
    NPJ Prim Care Respir Med; 2016 Jun; 26():16027. PubMed ID: 27279354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term exposure to outdoor air pollution and the incidence of chronic obstructive pulmonary disease in a national English cohort.
    Atkinson RW; Carey IM; Kent AJ; van Staa TP; Anderson HR; Cook DG
    Occup Environ Med; 2015 Jan; 72(1):42-8. PubMed ID: 25146191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD).
    Raslan AS; Quint JK; Cook S
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1207-1218. PubMed ID: 37332839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and health burden of the undiagnosed population at risk of chronic obstructive pulmonary disease in China.
    Koch M; Butt T; Guo W; Li X; Chen Y; Tan D; Liu GG
    BMC Public Health; 2019 Dec; 19(1):1727. PubMed ID: 31870442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in the epidemiology of asthma in England: a national study of 333,294 patients.
    Simpson CR; Sheikh A
    J R Soc Med; 2010 Mar; 103(3):98-106. PubMed ID: 20200181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethnic differences in smoking intensity and COPD risk: an observational study in primary care.
    Gilkes A; Hull S; Durbaba S; Schofield P; Ashworth M; Mathur R; White P
    NPJ Prim Care Respir Med; 2017 Sep; 27(1):50. PubMed ID: 28871087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Socioeconomic variations in chronic obstructive pulmonary disease prevalence, diagnosis, and treatment in rural Southwest China.
    Cai L; Wang XM; Fan LM; Shen JR; Liu YN; Golden AR
    BMC Public Health; 2020 Apr; 20(1):536. PubMed ID: 32306944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study.
    Terzikhan N; Verhamme KM; Hofman A; Stricker BH; Brusselle GG; Lahousse L
    Eur J Epidemiol; 2016 Aug; 31(8):785-92. PubMed ID: 26946425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis.
    Adeloye D; Song P; Zhu Y; Campbell H; Sheikh A; Rudan I;
    Lancet Respir Med; 2022 May; 10(5):447-458. PubMed ID: 35279265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COPD prevalence and its association with occupational exposures in a general population.
    Melville AM; Pless-Mulloli T; Afolabi OA; Stenton SC
    Eur Respir J; 2010 Sep; 36(3):488-93. PubMed ID: 20110401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: A cross-sectional study.
    Jung JH; Lim JH; Bang CH; Seok H; Song GG; Choi SJ
    Int J Rheum Dis; 2021 Jun; 24(6):774-780. PubMed ID: 34036753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in the epidemiology and prescribing of medication for allergic rhinitis in England.
    Ghouri N; Hippisley-Cox J; Newton J; Sheikh A
    J R Soc Med; 2008 Sep; 101(9):466-72. PubMed ID: 18779249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes: A protective factor for COPD?
    Rayner LH; McGovern AP; Sherlock J; Gatenby P; Correa A; Creagh-Brown B; de Lusignan S
    Prim Care Diabetes; 2018 Oct; 12(5):438-444. PubMed ID: 29843977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study.
    Mytton OT; Jackson C; Steinacher A; Goodman A; Langenberg C; Griffin S; Wareham N; Woodcock J
    PLoS Med; 2018 Mar; 15(3):e1002517. PubMed ID: 29509767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in COPD prevalence and exacerbation rates in Dutch primary care.
    Bischoff EW; Schermer TR; Bor H; Brown P; van Weel C; van den Bosch WJ
    Br J Gen Pract; 2009 Dec; 59(569):927-33. PubMed ID: 19891824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic obstructive pulmonary disease and comorbidities: a large cross-sectional study in primary care.
    Chetty U; McLean G; Morrison D; Agur K; Guthrie B; Mercer SW
    Br J Gen Pract; 2017 May; 67(658):e321-e328. PubMed ID: 28450344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active asthma and the prevalence of physician-diagnosed COPD.
    Mirabelli MC; Beavers SF; Chatterjee AB
    Lung; 2014 Oct; 192(5):693-700. PubMed ID: 24952247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England.
    Sansbury LB; Rothnie KJ; Bains C; Compton C; Anley G; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2591-2604. PubMed ID: 34552325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019.
    Alqahtani JS
    PLoS One; 2022; 17(5):e0268772. PubMed ID: 35588429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of chronic obstructive pulmonary disease: a literature review.
    Rycroft CE; Heyes A; Lanza L; Becker K
    Int J Chron Obstruct Pulmon Dis; 2012; 7():457-94. PubMed ID: 22927753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.